Interleukin-6 receptor antagonists in critically ill patients with Covid-19 by Gordon, AC, Mouncey, PR, Al‑Beidh, F, Estcourt, LJ

A UK national survey of prophylactic platelet transfusion thresholds in non-bleeding, critically ill adults by Shah, A, Gould, DW, Doidge, J, Mouncey, PR, Harrison, DA, Young, JD, Stanworth, SJ, Watkinson, PJ

Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review by Drikite, L, Bedford, JP, O'Bryan, L, Petrinic, T, Rajappan, K, Doidge, J, Harrison, DA, Rowan, KM, Mouncey, PR, Young, J, Watkinson, PJ, Corbett, M

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care by Doidge, JC, Gould, DW, Sadique, Z, Borthwick, M, Hatch, RA, Caskey, FJ, Forni, L, Lawrence, RF, MacEwan, C, Ostermann, M, Mouncey, PR, Harrison, DA, Rowan, KM, Young, JD, Watkinson, P

Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study by Gould, DW, Doidge, J, Sadique, MZ, Borthwick, M, Hatch, R, Caskey, FJ, Forni, L, Lawrence, RF, MacEwen, C, Ostermann, M, Mouncey, PR, Harrison, DA, Rowan, KM, Young, JD, Watkinson, PJ

Cost-effectiveness of high flow nasal cannula therapy versus continuous positive airway pressure for non-invasive respiratory support in paediatric critical care by Sadique, Z, Zapata, SM, Grieve, R, Richards-Belle, A, Lawson, I, Darnell, R, Lester, J, Morris, KP, Tume, LN, Davis, PJ, Peters, MJ, Feltbower, RG, Mouncey, PR, Harrison, DA, Rowan, KM, Ramnarayan, P

Virological and serological characterization of critically ill patients with COVID-19 in the UK: interactions of viral load, antibody status and B.1.1.7 variant infection by Ratcliff, J, Nguyen, D, Fish, M, Rynne, J, Jennings, A, Williams, S, Al-Beidh, F, Bonsall, D, Evans, A, Golubchik, T, Gordon, AC, Lamikanra, A, Tsang, P, Ciccone, NA, Leuscher, U, Slack, W, Laing, E, Mouncey, PR, Ziyenge, S, Oliveira, M, Ploeg, R, Rowan, KM, Shankar-Hari, M, Roberts, DJ, Menon, DK, Estcourt, L, Simmonds, P, Harvala, H

Highly sensitive lineage discrimination of SARS-CoV-2 variants through allele-specific probe PCR by Ratcliff, J, Al-Beidh, F, Bibi, S, Bonsall, D, Costa Clemens, SA, Estcourt, L, Evans, A, Fish, M, Folegatti, PM, Gordon, AC, Jay, C, Jennings, A, Laing, E, Lambe, T, MacIntyre-Cockett, G, Menon, D, Mouncey, PR, Nguyen, D, Pollard, AJ, Ramasamy, MN, Roberts, DJ, Rowan, KM, Rynne, J, Shankar-Hari, M, Williams, S, Harvala, H, Golubchik, T, Simmonds, P

Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial by Bradbury, CA, Lawler, PR, Stanworth, SJ, McVerry, BJ, McQuilten, Z, Higgins, AM, Mouncey, PR, Al-Beidh, F, Rowan, KM, Berry, LR, Lorenzi, E, Zarychanski, R, Arabi, YM, Annane, D, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bihari, S, Bonten, MJM, Brunkhorst, FM, Buzgau, A, Buxton, M, Carrier, M, Cheng, AC, Cove, M, Detry, MA, Estcourt, LJ, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Huang, DT, Horvat, CM, Hunt, BJ, Ichihara, N, Lamontagne, F, Leavis, HL, Linstrum, KM, Litton, E, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, Middeldorp, S, Montgomery, SK, Morpeth, SC, Murthy, S

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial by Arabi, YM, Gordon, AC, Derde, LPG, Nichol, AD, Murthy, S, Beidh, FA, Annane, D, Swaidan, LA, Beane, A, Beasley, R, Berry, LR, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Buzgau, A, Cheng, A, De Jong, M, Detry, MA, Duffy, EJ, Estcourt, LJ, Fitzgerald, M, Fowler, R, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Higgins, AM, Hills, TE, Horvat, CM, Huang, DT, King, AJ, Lamontagne, F, Lawler, PR, Lewis, R, Linstrum, K, Litton, E, Lorenzi, E, Malakouti, S, McAuley, DF, McGlothlin, A, Mcguinness, S, McVerry, BJ, Montgomery, SK, Morpeth, SC, Mouncey, PR, Orr, K, Parke, R, Parker, JC

Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-cap randomized clinical trial by Higgins, AM, Berry, LR, Lorenzi, E, Murthy, S, McQuilten, Z, Mouncey, PR, Al-Beidh, F, Annane, D, Arabi, YM, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Burrell, A, Buzgau, A, Buxton, M, Charles, WN, Cove, M, Detry, MA, Estcourt, LJ, Fagbodun, EO, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Horvat, CM, Huang, DT, Ichihara, N, Lamontagne, F, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, McVerry, BJ, Neal, MD, Nichol, AD, Parke, RL, Parker, JC, Parry-Billings, K, Peters, SEC, Reyes, LF, Rowan, KM, Saito, H, Santos, MS, Saunders, CT